Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 2
2006 2
2008 3
2009 3
2010 6
2011 12
2012 12
2013 16
2014 21
2015 25
2016 24
2017 17
2018 38
2019 52
2020 43
2021 74
2022 64
2023 77
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

465 results

Results by year

Filters applied: . Clear all
Page 1
Mitochondrial Fusion: The Machineries In and Out.
Gao S, Hu J. Gao S, et al. Among authors: hu j. Trends Cell Biol. 2021 Jan;31(1):62-74. doi: 10.1016/j.tcb.2020.09.008. Epub 2020 Oct 19. Trends Cell Biol. 2021. PMID: 33092941 Free article. Review.
Small molecule agonist of mitochondrial fusion repairs mitochondrial dysfunction.
Guo Y, Zhang H, Yan C, Shen B, Zhang Y, Guo X, Sun S, Yu F, Yan J, Liu R, Zhang Q, Zhang D, Liu H, Liu Y, Zhang Y, Li W, Qin J, Lv H, Wang Z, Yuan Y, Yang JF, Zhong YT, Gao S, Zhou B, Liu L, Kong D, Hao X, Hu J, Chen Q. Guo Y, et al. Among authors: hu j. Nat Chem Biol. 2023 Apr;19(4):468-477. doi: 10.1038/s41589-022-01224-y. Epub 2023 Jan 12. Nat Chem Biol. 2023. PMID: 36635564
Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II-III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial.
Zhu X, Sun L, Song N, He W, Xie B, Hu J, Zhang J, Yang J, Dai J, Bian D, Xia H, Sun F, Xiong A, Luo J, Zhang L, Yu H, Liu M, Liu H, Wang H, Zhang H, Chen C, Wu C, Duan L, Zhu Y, Zhang P, Jiang G. Zhu X, et al. Among authors: hu j. BMC Med. 2022 Dec 30;20(1):493. doi: 10.1186/s12916-022-02696-4. BMC Med. 2022. PMID: 36581917 Free PMC article. Clinical Trial.
Ferroptosis as an emerging therapeutic target in liver diseases.
Lu Y, Hu J, Chen L, Li S, Yuan M, Tian X, Cao P, Qiu Z. Lu Y, et al. Among authors: hu j. Front Pharmacol. 2023 May 15;14:1196287. doi: 10.3389/fphar.2023.1196287. eCollection 2023. Front Pharmacol. 2023. PMID: 37256232 Free PMC article. Review.
465 results